Document Detail


Behavioral responses to intravenous meta-chlorophenylpiperazine in patients with seasonal affective disorder and control subjects before and after phototherapy.
MedLine Citation:
PMID:  7972574     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A comparison of the baseline and post-infusion effects of the serotonin agonist meta-chlorophenylpiperazine (m-CPP) in 10 patients with seasonal affective disorder (SAD) and 11 healthy control subjects revealed significantly different subjective response profiles between the groups. Several baseline and m-CPP-stimulated responses in symptoms putatively related to serotonergic function changed significantly after a week's exposure to phototherapy in the SAD patients but not the control subjects. Before phototherapy, depressed patients with SAD reported activation-euphoria responses to m-CPP and significant decreases in carbohydrate hunger, but insignificant changes in feeling slowed or sleepy, while control subjects reported no mood or appetite changes but significant increases in feeling slowed down following m-CPP. After phototherapy, which led to a significant reduction in baseline depressive symptom rating to near-euthymic levels in the SAD patients, almost all of the patients' responses to m-CPP were normalized and no longer differed from the control subjects' responses. These results provide evidence of a possible dysregulation in serotonergic neurotransmission in depressed SAD patients that normalizes following treatment with phototherapy.
Authors:
F M Jacobsen; E A Mueller; N E Rosenthal; S Rogers; J L Hill; D L Murphy
Related Documents :
21041614 - Relationship between amygdala responses to masked faces and mood state and treatment in...
23766044 - Update on antidepressant use during breastfeeding.
8911224 - Nocturnal serum melatonin profile in major depression in children and adolescents.
21721994 - Comparison of post-treatment effects of conventional and acupuncture-like transcutaneou...
3935644 - A double-blind comparative study of pelletized cromolyn versus cromolyn blend in the tr...
21095214 - Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophre...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Psychiatry research     Volume:  52     ISSN:  0165-1781     ISO Abbreviation:  Psychiatry Res     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-11-28     Completed Date:  1994-11-28     Revised Date:  2008-04-17    
Medline Journal Info:
Nlm Unique ID:  7911385     Medline TA:  Psychiatry Res     Country:  IRELAND    
Other Details:
Languages:  eng     Pagination:  181-97     Citation Subset:  IM    
Affiliation:
Laboratory of Clinical Science, National Institute of Mental Health (NIMH), Bethesda, MD 20892.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Humans
Injections, Intravenous
Male
Phototherapy*
Piperazines / administration & dosage,  diagnostic use*,  pharmacology
Questionnaires
Seasonal Affective Disorder / metabolism*,  therapy*
Serotonin / metabolism*
Chemical
Reg. No./Substance:
0/Piperazines; 50-67-9/Serotonin; 6640-24-0/1-(3-chlorophenyl)piperazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factor structure of the negative symptom assessment.
Next Document:  Heat-loss response to a thermal challenge in seasonal affective disorder.